Rights and Procedures. If either Party determines that any HPA Patent is being infringed by a Third Party’s activities and that such infringement could affect the exercise by Emergent of its rights and obligations under this Agreement, it shall notify the other Party in writing and provide it with any evidence of such infringement that is reasonably available. Emergent shall have the first right, but not the obligation, to attempt to remove such infringement by commercially appropriate steps, including filing an infringement suit or taking other similar action, at its own expense. If required by law in order for Emergent to prosecute such suit, HPA shall join such suit as a Party, at Emergent’s expense. HPA shall use its best efforts to obtain any consents required by Third Parties owning Licensed HPA Patents in order to authorize Emergent to take legal action to remove such infringement. In the event Emergent fails within one hundred and twenty (120) days following notice of such infringement, or earlier notifies HPA in writing of its intent not to take commercially appropriate steps to remove any infringement of any such HPA Patent, HPA may do so at its own expense; provided, however, that if HPA fails to bring such suit or otherwise terminate such infringement within one hundred and twenty (120) days of its first having the right to do so, Emergent shall be permanently relieved of its royalty obligations under this Agreement until the earlier of (a) the date such suit is commenced, provided that Emergent shall be relieved of such obligations during any period that HPA is not diligently prosecuting such suit, and (b) the date that such infringement is otherwise terminated. The Party not enforcing the applicable HPA Patent shall provide reasonable assistance to the other Party, including providing access to relevant documents and other evidence, making its employees available at reasonable business hours, and joining the action to the extent necessary to allow the enforcing Party to maintain the action.
Appears in 2 contracts
Sources: Rbot Vaccine License Agreement (Emergent BioSolutions Inc.), Bt Vaccine License Agreement (Emergent BioSolutions Inc.)
Rights and Procedures. If In the event that either Party determines reasonably believes that any HPA Patent is being infringed by a Third Party’s activities and that Party may be infringing any of the GPC Biotech Patents, the Licensee Patents, the Joint Patents or the Product Trademarks, such infringement could affect the exercise by Emergent of its rights and obligations under this Agreement, it Party shall promptly notify the other Party in writing writing, identifying the alleged infringer and provide the alleged infringement complained of and furnishing the information upon which such determination is based. With respect to the GPC Biotech Patents, the Joint Patents and the Product Trademarks, GPC Biotech shall, subject to the Spectrum Agreement, have the first right, but not the obligation, through counsel of its choosing, to take any measures it deems appropriate to stop such infringing activities by such Third Party in any part of the Territory or, to the extent not in conflict with any evidence the terms of this Agreement, to grant the infringing Third Party adequate rights and licenses necessary for continuing such infringement that is reasonably availableactivities. Emergent With respect to the Licensee Patents, Licensee shall have the first right, but not the obligation, through counsel of its choosing, to attempt take any measures it deems appropriate to remove stop such infringement infringing activities by commercially appropriate stepssuch Third Party in any part of the Territory or, to the extent not in conflict with the terms of this Agreement, to grant the infringing Third Party adequate rights and licenses necessary for continuing such activities. Upon reasonable request by the enforcing Party, the other Party shall give the enforcing Party all reasonable information and assistance, including filing an infringement suit or taking allowing the enforcing Party access to the other similar Party’s files and documents and to the other Party’s personnel who may have possession of relevant information and, if necessary for the enforcing Party to prosecute any legal action, joining in the legal action as a party at its own expense. If required by law in order for Emergent to prosecute such suit, HPA shall join such suit as a Party, at Emergent’s expense. HPA shall use its best efforts to obtain any consents required by Third Parties owning Licensed HPA Patents in order to authorize Emergent to take legal action to remove such infringement. In the event Emergent the enforcing Party fails within one hundred and twenty ninety (12090) days following notice of such infringement, as provided in the first sentence of this Section 8.3.1, or earlier notifies HPA the other Party in writing of its intent not to take commercially appropriate steps to remove stop any infringement of any such HPA (a) GPC Biotech Patent, HPA may Joint Patent or Product Trademark in the Licensee Territory, in the case of GPC Biotech, or (b) Licensee Patent in the Territory, in the case of Licensee, that is likely or could reasonably be expected to have a material adverse effect on the sale of the Licensed Product in the Territory and the enforcing Party has not granted the infringing Third Party rights and licenses to continue its otherwise infringing activities, then, unless the enforcing Party provides the other Party with a commercially reasonable basis in writing for not taking such steps, the other Party shall have the right, but not the obligation, to do so at its own the other Party’s sole cost and expense; provided, however, that if HPA fails to bring such suit or otherwise terminate the enforcing Party has commenced negotiations with an alleged infringer for discontinuance of such infringement within one hundred and twenty such ninety (12090) day period, the enforcing Party shall have an additional ninety (90) days of to conclude its first having negotiations before the right to do so, Emergent shall be permanently relieved of its royalty obligations under this Agreement until the earlier of (a) the date other Party may bring suit for such suit is commenced, provided that Emergent shall be relieved of such obligations during any period that HPA is not diligently prosecuting such suit, and (b) the date that such infringement is otherwise terminatedinfringement. The Party not enforcing the applicable HPA Patent shall provide Upon reasonable assistance to request by the other Party, including providing access to relevant documents and other evidence, making its employees available at reasonable business hours, and joining the action to the extent necessary to allow the enforcing Party to maintain shall give the actionother Party all reasonable information and assistance in connection with such suit for infringement.
Appears in 2 contracts
Sources: Co Development and License Agreement (GPC Biotech Ag), Co Development and License Agreement (Pharmion Corp)
Rights and Procedures. If In the event that either Party determines has cause to believe that any HPA Patent is being infringed by a Third Party’s activities and that such infringement could affect Party may be infringing any of the exercise by Emergent of its rights and obligations under this AgreementLicensed Patents, Licensee Patents or Joint Patents in the Field in the Territory, it shall promptly notify the other Party in writing writing, identifying the alleged infringer and provide it with the alleged infringement complained of and furnishing the information upon which such determination is based. Subject to any evidence rights of such infringement that is reasonably available. Emergent Tulane under the Tulane License, Licensee shall have the first right, but not the obligation, through counsel of its choosing, to attempt take measures to remove stop such infringement of the Licensed Patents or Joint Patents by commercially appropriate stepssuch Third Party in the Field in the Territory or to grant to the infringing Third Party adequate rights and licenses necessary for continuing the otherwise infringing activities in the Field in the Territory. Licensee shall control such action and, upon reasonable request by Licensee, Licensor shall give Licensee all reasonable information and assistance, including filing an infringement suit or taking other similar allowing Licensee access to Licensor's files and documents and to Licensor's personnel who may have possession of relevant information and, if necessary for Licensee to prosecute any legal action, at its own expense. If required by law joining in order for Emergent to prosecute such suit, HPA shall join such suit the legal action as a Partyparty, at Emergent’s expenseand the Parties shall share Licensor's reasonable costs and expenses incurred with respect to such joinder in accordance with Section 9.3.4. HPA Licensor shall use its best efforts Commercially Reasonable Efforts to obtain any consents required by Third Parties owning Licensed HPA Patents in order to authorize Emergent to take legal action Tulane under the Tulane License to remove such infringement. In the event Emergent If Licensee fails within one hundred and twenty ninety (12090) days following notice of such infringement, or earlier notifies HPA Licensor in writing of its intent not to take commercially appropriate steps to remove any infringement of any such HPA Licensed Patent or Joint Patent, HPA may do so and Licensee has not granted the infringing Third Party rights and licenses to continue its otherwise infringing activities, then Licensor shall have the right to remove such infringement at its own Licensor's expense; providedPROVIDED, howeverHOWEVER, that if HPA fails to bring such suit or otherwise terminate Licensee has commenced negotiations with an alleged infringer for discontinuance of such infringement within one hundred and twenty such ninety (12090) day period, Licensee shall have an additional ninety (90) days of to conclude its first having the right to do sonegotiations before Licensor may bring suit for such infringement. Upon reasonable request by Licensor and at Licensor's cost and expense, Emergent Licensee shall be permanently relieved of its royalty obligations under this Agreement until the earlier of (a) the date give Licensor all reasonable information and assistance in connection with such suit is commenced, provided that Emergent shall be relieved of such obligations during any period that HPA is not diligently prosecuting such suit, and (b) the date that such infringement is otherwise terminated. The Party not enforcing the applicable HPA Patent shall provide reasonable assistance to the other Party, including providing access to relevant documents and other evidence, making its employees available at reasonable business hours, and joining the action to the extent necessary to allow the enforcing Party to maintain the actionfor infringement.
Appears in 1 contract
Sources: Development, Commercialization and License Agreement (Aeterna Zentaris Inc.)